Literature DB >> 15645612

Acute renal failure and rhabdomyolysis.

K H Polderman1.   

Abstract

The clinical syndrome of rhabdomyolysis is caused by injury of skeletal muscles, leading to the release of various intracellular muscle constituents. Rhabdomyolysis occurs frequently but is usually asymptomatic (i.e., lab abnormalities only). However, in more serious cases, severe electrolyte disorders and acute renal failure may occur, leading to life-threatening situations. Rhabdomyolysis can develop in any circumstances where energy demands in muscles exceed the available energy supplies; it accounts for between 2 and 5% of all cases of acute renal failure in the ICU. Frequent causes of severe rhabdomyolysis include crush injuries, prolonged immobilization, seizures, severe infections and drug toxicity. Factors contributing to the development of more severe clinical symptoms include hypovolemia, hyperthermia, electrolyte disorders and the presence of pre-existing (congenital) muscle disorders. The diagnosis is established by elevation of serum muscle enzymes and muscle constituents such as creatinine phosphokinase and myoglobin. Preventive measures include maintenance of normal or high intravascular volume and administration of diuretics (loop diuretics rather than mannitol) once hypervolemia/euvolemia have been achieved. Some evidence suggests that early initiation of renal replacement therapy can help improve outcome. Administration of bicarbonate to induce urinary alkalosis can be considered, but it has not been proven to be effective.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15645612     DOI: 10.1177/039139880402701204

Source DB:  PubMed          Journal:  Int J Artif Organs        ISSN: 0391-3988            Impact factor:   1.595


  10 in total

1.  Lower leg compartment syndrome following prolonged orthopedic surgery in the lithotomy position -A case report-.

Authors:  Jin Hun Chung; Ki Ryang Ahn; Jin Hyung Park; Chun Sook Kim; Kyu Sik Kang; Sie Hyeon Yoo; Ji Won Chung; Nan Seol Kim; Seung Jin Lee
Journal:  Korean J Anesthesiol       Date:  2010-12-31

Review 2.  Rhabdomyolysis: diagnosis and treatment in bariatric surgery.

Authors:  João E M T M Ettinger; Carlos A Marcílio de Souza; Paulo V Santos-Filho; Euler Azaro; Carlos A B Mello; Edvaldo Fahel; Paulo B P Batista
Journal:  Obes Surg       Date:  2007-04       Impact factor: 4.129

3.  Recovery from glycerol-induced acute kidney injury is accelerated by suramin.

Authors:  Midhun C Korrapati; Brooke E Shaner; Rick G Schnellmann
Journal:  J Pharmacol Exp Ther       Date:  2012-01-06       Impact factor: 4.030

4.  Acute renal failure due to rhabdomyolysis after proximal humerus fracture associated with axillary artery rupture.

Authors:  G Mouzopoulos; N Lasanianos; D Mouzopoulos; G Batanis; M Tzurbakis; I Georgilas
Journal:  Int Urol Nephrol       Date:  2008-06-28       Impact factor: 2.370

Review 5.  Rhabdomyolysis.

Authors:  W H Bagley; H Yang; K H Shah
Journal:  Intern Emerg Med       Date:  2007-10-01       Impact factor: 3.397

6.  Fatal rhabdomyolysis in systemic lupus erythematosus.

Authors:  Jozélio Freire de Carvalho; Licia Maria Henrique da Mota; Eloisa Bonfa
Journal:  Rheumatol Int       Date:  2010-12-03       Impact factor: 3.580

7.  Clinical spectrum of rhabdomyolysis presented to pediatric emergency department.

Authors:  Chun-Yu Chen; Yan-Ren Lin; Lu-Lu Zhao; Wen-Chieh Yang; Yu-Jun Chang; Kang-Hsi Wu; Han-Ping Wu
Journal:  BMC Pediatr       Date:  2013-09-03       Impact factor: 2.125

Review 8.  Clinical review: timing of renal replacement therapy.

Authors:  Michael Joannidis; Lui G Forni
Journal:  Crit Care       Date:  2011-06-10       Impact factor: 9.097

9.  Post-traumatic acute kidney injury: a cross-sectional study of trauma patients.

Authors:  Wei-Hung Lai; Cheng-Shyuan Rau; Shao-Chun Wu; Yi-Chun Chen; Pao-Jen Kuo; Shiun-Yuan Hsu; Ching-Hua Hsieh; Hsiao-Yun Hsieh
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2016-11-22       Impact factor: 2.953

10.  Renoprotective effect of long acting thioredoxin by modulating oxidative stress and macrophage migration inhibitory factor against rhabdomyolysis-associated acute kidney injury.

Authors:  Kento Nishida; Hiroshi Watanabe; Shigeru Ogaki; Azusa Kodama; Ryota Tanaka; Tadashi Imafuku; Yu Ishima; Victor Tuan Giam Chuang; Masao Toyoda; Masumi Kondoh; Qiong Wu; Masafumi Fukagawa; Masaki Otagiri; Toru Maruyama
Journal:  Sci Rep       Date:  2015-09-28       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.